Scott K. Reed is co-chair of the IP Litigation Practice Group. Scott has served as lead trial counsel in complex patent litigations involving pharmaceuticals, biotechnology, chemicals, and electronic and computer technologies, in bench and jury trials in federal and state court and in contested proceedings before the U.S. Patent and Trademark Office.
Before joining Venable, Scott spent his entire career at Fitzpatrick, Cella, Harper & Scinto, where he chaired the Litigation Practice Group and served as a member of the Management Committee.
- Alkermes in Luye Pharma v. Alkermes (injectable suspensions, including a long-acting injection of risperidone used to treat schizophrenia)
- Allergan in Allergan v. Aurobindo, Wilshire and Sometset (ophthalmic formulations of alcaftadine for once-daily treatment of allergic conjunctivitis)
- Astellas in Astellas v. Actavis, Sandoz, Sawai, Lupin, Zydus, Prinston, Aurobindo, Apotex and Windlas(compound to treat overactive bladder)
- Canon in Intellectual Ventures v. Canon (graphical user interface and image sensor technology); Honeywell v. Canon (autofocus camera technology); and Gross v. Canon (microprocessor technology and optical devices)
- Emory University in Emory University v. Glaxo Wellcome (anti-hepatitis pharmaceuticals) and Emory University v. Glaxo Wellcome and BioChem Pharma (anti-AIDS pharmaceuticals)
- Union Carbide in BP v. Union Carbide (polyethylene processing technology)
- J.D. Franklin Pierce Law Center 1987
- B.S. Chemistry and Economics Ursinus College 1984
Bar Admissions : New York, U.S. Patent and Trademark Office
Court Admissions :
- U.S. District Court for the Southern District of New York
- U.S. District Court for the Eastern District of New York
- U.S. District Court for the Western District of New York
Rate : $$$$